...
首页> 外文期刊>British Journal of Haematology >Outcomes of acute lymphoblastic leukaemia in adolescent and young adult Korean patients
【24h】

Outcomes of acute lymphoblastic leukaemia in adolescent and young adult Korean patients

机译:青少年和年轻成人韩国患者急性淋巴细胞白血病的结果

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract This study used Korean national data to investigate the relationship between treatment patterns and outcomes in Korean adolescent and young‐adult (AYA) acute lymphoblastic leukaemia (ALL) patients. Chemotherapy incorporating L‐asparaginase was considered paediatric‐inspired (PI), as opposed to adult protocols. In total, 65·3% of patients received PI therapy. Five‐year overall survival (OS) of PI‐treated patients outperformed adult protocols (63·1% vs. 40·4%; P ??0·0001); this trend was maintained within various age subgroups. Younger age, L‐asparaginase therapy, and radiotherapy corresponded with superior OS by multivariable analysis. OS tends to improve with PI protocols that include L‐asparaginase in AYA ALL, suggesting that therapy protocol is critical in the treatment performance of this group.
机译:摘要本研究采用韩国国家数据调查韩国青少年和年轻成人(AYA)急性淋巴细胞白血病(全)患者的治疗模式和结果之间的关系。 与成年方案相比,将掺入L-天冬酰胺酶的化疗被认为是儿科强烈的(PI)。 总共65·3%的患者接受了PI治疗。 PI治疗患者的五年整体存活(OS)表现优于成人方案(63·1%对40·4%; P?&?0·0001); 这种趋势是在各个年龄次组中保持的。 年轻的年龄,L-天冬酰胺酶治疗和放射治疗与多变量分析相对应的优质操作系统。 OS倾向于通过在AYA的L-天冬酰胺酶中包含L-天冬酰胺酶的PI方案来改善,这表明治疗方案在该组的治疗性能至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号